← Leaderboards
Peter David Suzdak
Sonoval Llc
$1,791,941
Attributed
$4,250,548
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,250,548 · 2
By mechanism
R44$4,250,548 · 2
Top collaborators
- William Ramses Bishai5 shared
- John R. Murphy2 shared
Others in their field
Other Emerging Leaders on “Generations”
- Klaus Romero · Critical Path Institute$88,602,036
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,130,757
- Scott Topper · Broad Institute, Inc.$60,777,399
- John Damon Chodera · Sloan-Kettering Inst Can Research$59,941,649
Research focus
GenerationsImmune Checkpoint InhibitorCutaneous T-Cell LymphomaDoseImmuneIl2ra GeneColon CarcinomaCorynebacterium DiphtheriaeDetergentsDisease ProgressionCt26HomeostasisAffinityIl2 GeneAmericanBlood VesselsAntitumor EffectChimeric ProteinsAnti-Tumor Immune ResponseDenileukin DiftitoxCellsCell TypeAntineoplastic AgentsImmunotherapy
Grant awards (5)
Immunotherapy to deplete key Treg subsets in solid tumors$706,495
R44 · FY2025 · CA · contact PI
Immunotherapy to deplete key Treg subsets in solid tumors$1,293,505
R44 · FY2024 · CA · contact PI
Treg-depleting immunotherapy$811,405
R44 · FY2022 · CA · contact PI
Treg-depleting immunotherapy$1,188,595
R44 · FY2021 · CA · contact PI
Treg-depleting immunotherapy$250,548
R44 · FY2020 · CA · contact PI